"the big unanswered question is concerns over safety in pregnancy," she says. cgrp levels are lower than normal in pregnant women who have
.
marketwatch: "new migraine drugs have promise -- and a ,500 price tag."
.
.
.
.
the daily californian covers the city of berkeley and the campus in unparalleled detail, all while training the future of the journalism industry.
.
schneider said that he is "not aware of any relevant risk of the drug" and that his team has "not observed side effects in thousands of treated animals."
.